GlassScriptPhysician profile
Snehitha Vijaykumar
NPI 1376960526
$13,534.21
in general payments reported to CMS, 2019-2025
23 companies · $86.10 in 2025
The $86.10 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $8,958 · 2021: $2,327 · 2022: $402 · 2023: $1,073 · 2024: $33.83 · 2025: $86.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655 · Travel and Lodging: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.33 |
| Travel and Lodging | $538.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $7,605.65 | 2019-2020 | |
| Abbott Laboratories | $1,594.31 | 2019-2024 | Optis, Pressurewire, Diamondback Coronary |
| Boston Scientific Corporation | $1,171.83 | 2020-2025 | General - Vascular Intervention, General - Therapies |
| Edwards Lifesciences Corporation | $930.96 | 2021 | |
| Cardiovascular Systems INC. | $441.48 | 2019-2022 | |
| Medtronic, INC. | $406.63 | 2021-2025 | Micra |
| Shockwave Medical, INC | $242.87 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $240.00 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $153.89 | 2019-2022 | |
| Cardinal Health 200 LLC | $147.43 | 2020-2021 | |
| Amgen INC. | $140.84 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Pfizer INC. | $62.25 | 2019-2025 | |
| Terumo Medical Corporation | $51.10 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.75 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.29 | 2022-2024 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $29.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.12 | 2021 | |
| Philips North America LLC | $23.99 | 2020 | |
| Inari Medical, INC. | $15.83 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Daiichi Sankyo INC. | $14.86 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.85 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Snehitha Vijaykumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.